Capital Fund Management (CFM)’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.1M | Buy |
329,554
+187,353
| +132% | +$14.1M | 0.12% | 215 |
|
|
2026
Q1 | $10.7M | Buy |
+142,201
| New | +$11.2M | 0.05% | 529 |
|
|
2025
Q3 | – | Sell |
-31,219
| Closed | -$1.23M | – | 2567 |
|
|
2025
Q2 | $1.23M | Sell |
31,219
-26,795
| -46% | -$877K | ﹤0.01% | 1922 |
|
|
2025
Q1 | $1.75M | Buy |
+58,014
| New | +$1.9M | 0.01% | 1472 |
|
|
2024
Q4 | – | Sell |
-30,691
| Closed | -$1.23M | – | 2134 |
|
|
2024
Q3 | $1.23M | Buy |
+30,691
| New | +$1.43M | ﹤0.01% | 1621 |
|
|
2023
Q2 | – | Sell |
-11,314
| Closed | -$404K | – | 1779 |
|
|
2023
Q1 | $404K | Buy |
+11,314
| New | +$425K | ﹤0.01% | 1471 |
|
|
2022
Q4 | – | Sell |
-23,023
| Closed | -$1.02M | – | 1494 |
|
|
2022
Q3 | $1.02M | Sell |
23,023
-16,087
| -41% | -$678K | 0.01% | 1083 |
|
|
2022
Q2 | $1.45M | Sell |
39,110
-5,609
| -13% | -$212K | 0.01% | 946 |
|
|
2022
Q1 | $1.66M | Buy |
44,719
+16,611
| +59% | +$544K | 0.01% | 1023 |
|
|
2021
Q4 | $855K | Buy |
+28,108
| New | +$885K | 0.01% | 1323 |
|
|
2020
Q4 | – | Sell |
-23,783
| Closed | -$1.13M | – | 1412 |
|
|
2020
Q3 | $1.13M | Buy |
+23,783
| New | +$1.32M | 0.01% | 842 |
|
|
2020
Q2 | – | Sell |
-33,111
| Closed | -$1.56M | – | 1285 |
|
|
2020
Q1 | $1.56M | Sell |
33,111
-25,377
| -43% | -$1.41M | 0.02% | 604 |
|
|
2019
Q4 | $3.53M | Buy |
58,488
+15,282
| +35% | +$911K | 0.03% | 652 |
|
|
2019
Q3 | $2.59M | Sell |
43,206
-12,243
| -22% | -$798K | 0.02% | 709 |
|
|
2019
Q2 | $3.56M | Buy |
55,449
+21,328
| +63% | +$1.51M | 0.03% | 629 |
|
|
2019
Q1 | $2.77M | Buy |
+34,121
| New | +$2.2M | 0.02% | 687 |
|
|
2018
Q4 | – | Sell |
-21,024
| Closed | -$1.08M | – | 2022 |
|
|
2018
Q3 | $1.08M | Buy |
+21,024
| New | +$988K | 0.01% | 1341 |
|
|
2018
Q2 | – | Sell |
-6,140
| Closed | -$271K | – | 2120 |
|
|
2018
Q1 | $271K | Buy |
+6,140
| New | +$312K | ﹤0.01% | 1661 |
|
|
2017
Q4 | – | Sell |
-30,038
| Closed | -$1.52M | – | 1888 |
|
|
2017
Q3 | $1.52M | Sell |
30,038
-57,082
| -66% | -$2.99M | 0.01% | 840 |
|
|
2017
Q2 | $4.43M | Buy |
+87,120
| New | +$4.06M | 0.04% | 505 |
|
|
2016
Q4 | – | Sell |
-18,638
| Closed | -$737K | – | 1755 |
|
|
2016
Q3 | $683K | Sell |
18,638
-65,026
| -78% | -$2.03M | 0.01% | 1092 |
|
|
2016
Q2 | $1.95M | Buy |
83,664
+19,678
| +31% | +$635K | 0.02% | 738 |
|
|
2016
Q1 | $2.59M | Sell |
63,986
-58,062
| -48% | -$2.36M | 0.03% | 631 |
|
|
2015
Q4 | $7.56M | Sell |
122,048
-436,695
| -78% | -$23.6M | 0.08% | 335 |
|
|
2015
Q3 | $22.6M | Buy |
558,743
+92,202
| +20% | +$4.77M | 0.25% | 95 |
|
|
2015
Q2 | $26.8M | Buy |
466,541
+458,139
| +5,453% | +$29.1M | 0.34% | 69 |
|
|
2015
Q1 | $535K | Sell |
8,402
-8,752
| -51% | -$594K | 0.01% | 1027 |
|
|
2014
Q4 | $1.06M | Sell |
17,154
-70,276
| -80% | -$3.47M | 0.01% | 864 |
|
|
2014
Q3 | $3.4M | Buy |
+87,430
| New | +$3.1M | 0.04% | 515 |
|
|
2014
Q2 | – | Sell |
-50,466
| Closed | -$1.59M | – | 1789 |
|
|
2014
Q1 | $2.18M | Sell |
50,466
-68,191
| -57% | -$3.31M | 0.03% | 656 |
|
|
2013
Q4 | $4.73M | Buy |
118,657
+80,485
| +211% | +$2.87M | 0.06% | 400 |
|
|
2013
Q3 | $1.43M | Sell |
38,172
-122,362
| -76% | -$3.66M | 0.02% | 744 |
|
|
2013
Q2 | $4.31M | Buy |
+160,534
| New | +$3.41M | 0.07% | 396 |
|
Other funds holding IONS
Capital Fund Management (CFM)'s IONS Position: Q2 2026 in Review
Capital Fund Management (CFM) increased its Ionis Pharmaceuticals (IONS) stake by 132% in Q2 2026, buying an estimated $14.1M and bringing the position to 329,554 shares worth $26.1M. The position accounts for 0.12% of the portfolio, ranked #215.
Capital Fund Management (CFM) first reported a position in IONS in Q2 2013 and has held it in 33 quarters since. The position peaked at $26.8M in Q2 2015. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.
- Capital Fund Management (CFM) held 329,554 shares of Ionis Pharmaceuticals worth $26.1M as of Q2 2026.
- Capital Fund Management (CFM) bought 187,353 Ionis Pharmaceuticals shares in Q2 2026, an estimated $14.1M.
- Ionis Pharmaceuticals made up 0.12% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #215 holding.
- Capital Fund Management (CFM) first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
- Capital Fund Management (CFM)'s Ionis Pharmaceuticals position peaked at $26.8M in Q2 2015.
- 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.
Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.